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Bridging the Gap: Integrating Psychiatric Care into Primary Care Settings 
for Depression Management 
A Qualitative Systematic Review of the Literature 
Background 
Mental wellness is the essential foundation upon which any human can hope to 
live a life in which one is able to thrive and contribute to society. Historically, however, 
the medical community has had difficulty in figuring out how to effectively deal with 
matters of the mind as opposed to that of the body. Despite that difficulty, authorities are 
now recognizing the importance of mental wellness and the true impact that mental 
illness can have on a society. Data from the World Health Organization show that mental 
illness had the second highest disease burden as demonstrated by loss of disability-
adjusted-life-years (DAL Ys) in established market economies like the United States 
around the world. According to the World Health organizations 2005 report, 31.7% of all 
years lived with disability are the result of neuropsychiatric disorders. 1 
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FIGURE 1: Contribution by different non~communicable diseases to disability-adjusted life~years worldwide in 2005 
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Despite the extent of the burden of illness, much of mental illness goes untreated and 
even more cases are undertreated2 both here in the United States and abroad. In 
particular, depression is commonly under diagnosed and undermanaged. Since depression 
is one of the most common mental health disorders, improved management of depression 
can help to reduce the burden of mental illness in this country. 
Amongst novel treatment methods, the idea of integration of psychiatric services 
into primary care settings seems to be a viable and logical solution to many of the issues 
that make consistent management of depression difficult. In this paper I will perform a 
qualitative systematic review of the current literature to ascertain if integration of 
psychiatric services into primary care settings is associated with improved outcomes in 
depression as demonstrated by improvements in individual patient outcomes. 
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Mental Illness in the United States 
In the United States, the burden of mental illness has far reaching implications. 
The Surgeon General's 1999 Report showed that 20% of the population of the United 
States are affected at some point in any given year by a diagnosable mental illness. 3 The 
same study showed that 15% of adults and 21% of children utilize the mental health 
system each year for mental health services. 3 A diagnosable mental health disorder is a 
deficit in one's mood, affect, thought process/content, personality, impulse control, or 
anxiety level. Common diagnoses include those listed in Table I. 
In addition to the morbidity experienced by the individual, there are great costs 
associated with these disorders. Mental health disorders in the United States, excluding 
alcohol and substance abuse, cost this country about $160 billion dollars annually.3 This 
cost is even greater when time lost in non-work related social (family, community) roles 
is considered . There are direct and indirect costs for the management of mental health. 
Direct costs include costs associated with the delivery of care and management of 
persons with a diagnosable mental health disorder. As of 1996, $69 billion dollars were 
spent on mental health services and $13 billion on substance abuse treatment. 3 
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This amounts to about 10% of all healthcare spending. This cost is shared by public funds 
(Medicaid, Medicare, state and local government sources), private funds (private 
insurers), and out of pocket consumer dollars (co pays). Indirect costs of mental health 
are estimated on the basis of lost productivity due to morbidity, premature death, or 
incarceration. This cost as of 1990 was estimated to be $79 billion dollars and has no 
doubt risen since then. 3 
Despite the impressive burden of illness and the great cost of mental illness, many 
factors still prevent adequate management of mental illness in the United States. Among 
these, health care provider efficacy in management of mental illness has room for 
improvement. The National Comorbidity Survey was commissioned in the early 1990's 
to determine the 12 month prevalence of diagnosable mental illnesses for a national 
probability sample here in the United States. This study found that almost 50% of 
respondents reported a lifetime prevalence of a mental health disorder and about 30% 
reported being affected by a mental health disorder within the last 12 months.4 This study 
found that of persons with a mental health disorder within the last 12 months, less than 
20% had received treatment within the last year.4 This study was repeated a decade later 
to find that there had been some improvement. The 2005 NCS Replication study found 
that while 41% of persons with a diagnosable mental illness over the last year received 
treatment within that same timeframe, only 32.7% of those treated received at most what 
is classified by the study as "minimally adequate treatment".2 This study further supports 
the fact that there is room for improvement in the management of patients with mental 
illness by United States physicians .. 
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Before takillg a closer look at the shortcomings of the mental health system in our 
country in order to find potential places for intervention, it is necessary to first describe 
and understand the structure of our nation's mental health. There are a variety of provider 
types and settings, both public and private, that together make up what is called the De 
Facto Mental Health Care System. This system is divided into four components3 : 
• Specialty Mental Health Sector- Consists of psychiatrists, psychologists, 
psychiatric nurses, and psychiatric social workers. Less than 6% of the US 
population utilizes services within this sector. 
• General MedicaVPrimary Care Sector- Consists of internists, family care 
physicians, pediatricians, nurse practitioners, and nursing home staff. 
About 6% of the US population utilizes services within this sector. 
• Human Services Sector- Consists of school-based counselors, residential 
rehab services, and faith based counselors. About 5% of the US population 
uses these types of services. 
• Volunteer Support Network Sector- Consists of self-help groups and peer 
counselor settings. About 3% of the US population received care in this 
setting. 
Professionals in each of these sectors have different types of training that they use to 
approach persons with mental health disorders. Each sector also comes with its own set 
oflimitations in terms of time, resources, and skill sets. Treatment modalities include 
psychotherapy, psychodynamic therapy, cognitive behavioral therapy, humanistic 
therapy, pharmacotherapy, and complementary/alternative therapy. Psychotherapy is 
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"talk therapy" that can be performed individually, in couples, or in a group. During a 
session, patients present their problems to the mental health provider (psychiatrist, 
psychologist or trained licensed counselor) and the provider helps the client to develop a 
more effective means of understanding and handling their problem. 3 Psychodynamic 
therapy also involves an oral exchange but the focus of psychodynamic therapy is to 
unravel a patient's past in order to see how it has affected that person's present. This is 
generally performed by psychiatrists, psychologists, or trained licensed counselors. 
Cognitive behavioral therapy addresses a person's thoughts and actions head on to find 
ways to de-condition various behaviors in a patient. Similar to the previously mentioned 
forms of therapy, this is performed by mental health sector professionals (psychiatrists, 
psychologists, and trained licensed counselors). Humanistic therapy hinges on the 
relationship and rapport between the client and provider and focuses on current problems 
to decipher direction for the future. Humanistic therapy can be performed by 
professionals in the mental health sector, religious or spiritual advisors, social workers, or 
any other counselor not from a mental health setting. 
Pharmacotherapy for psychiatric illness refers to medications that work generally 
by altering the level of various neurotransmitters in the brain. While, pharmacotherapy 
offers great promise for management of many mental health disorders and also expands 
the scope of potential providers so that primary care physicians who are not trained in 
various forms of psychotherapy have viable tools in their arsenal for managing their 
patients with mental health disorders, it can potentially have its own set oflirnitations as 
well. Between 1987 and 1997, the amount of recognized depression had tripled5• During 
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that same time the number of people receiving antidepressants had increased (37.3% to 
74.5%), while the percentage receiving psychotherapy had decreased (71.1% to 60.2%)5. 
A systematic review of the literature done in 2004 suggests that not only is psychotherapy 
in addition to pharmacotherapy associated with better depression outcomes, but 
psychotherapy was also associated with better compliance with pharmacotherapl. This 
indicates that pharmacotherapy alone is not the complete answer for management of 
depression in primary care settings or otherwise. 
Depression in the United States 
Major Depressive Episodes, as defined by the Diagnostic and Statistical Manual 
of Mental Disorders IV, is diagnosed in the presence of five or more of nine depressive 
symptoms within a two week period, presenting as a change from previous functioning 
that is not clearly due to a general medical condition or other psychiatric disorder. 
Symptoms for diagnostic criteria include depressed mood, decreased interest in 
pleasurable activities, significant changes in weight, changes in sleeping habits, 
significant changes in motor activity, fatigue/energy loss, feelings of guilt, difficulty 
concentrating, thoughts of death and/or suicide. Major Depressive Disorder can be 
categorized as a single episode or recurrent, then further categorized as mild, moderate, 
and severe with or without psychosis? Patients with depression can experience a myriad 
of symptoms. The majority of patients who present to medical attention are asking to be 
seen for some physical symptom outside of the recognized criteria for diagnosis. 
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In 1990, it was estimated that depression costs annually were $43.7 billion, 
including $12.4 billion in direct costs oftreatment.8 In a study that compared lost 
productivity in the workplace between patients with and without depression, it was 
shown that workers in the United States with depression cost employers an estimated $31 
billion dollars more in lost productivity each year than their counterparts without 
d . 9 epresswn. 
One in five of all persons overall will develop a depressive episode at some point 
during their lives. This makes depression the second most common mental disorder after 
anxiety disorders. The lifetime prevalence for Major Depressive episodes, according to 
2 - 10 the data, ranges from I 0-25% for women and from 5-12% for men ''· . However, 
estimates are given because it is largely speculated that depression frequently goes 
unrecognized and undertreated 11 . Patient factors and physician factors can lead to this 
undertreatment and underrecognition. 
National trends in outpatient management of depression suggest that most people 
with depression don't receive any treatment for their symptoms5. Depressed patients are 
often unlikely to seek care for a variety of reasons. Ups and downs can be normal in a 
person's life, so it may be difficult for patients to realize that a particular down episode 
has crossed into the realm of clinical depression. Studies show that of persons with a 1 
year disorder only 20% had sought treatment within the last year from a medical 
professional11 . Even amongst patients with the most severe cases of depression, who are 
more likely to seek treatment, only 35.3% have sought treatment in their lifetime11 . Even 
if patients are able to recognize the need for professional help, the potential for 
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stigmatization may also keep patients from seeking help for fear of a negative impact on 
their employment, health insurance, and potentially personal relationships 12 Also, 
differences in help seeking behaviors between groups might make counsel from spiritual 
advisors or other human services sector providers seem more acceptable than seeking 
care from a medical professional. Lastly, in a nation where nearly 50 million people are 
uninsured and many more underinsured, it is plausible that mental health issues may 
potentially have to take a back seat to other more immediate financial obligations. 
Patients seek help for depression from a variety of places. There is quite a bit of 
overlap when it comes to the type of provider that treats patients with recognized 
depression. Forty three percent of persons with depression receive care in general 
medical sector13 while 40% of people who receive care for depression are seen in the 
mental health sector13. Lastly, 20% are seen in human services sector13 . Depression is 
underrecognized in all settings 13 . Similar to other mental illnesses, more patients with 
depression are seen in the primary care setting than in the mental health services sector. 
However, studies show that primary care physicians fail to recognize 30-50% of 
depressed patients.14 Doctor visits with patients who have physical symptoms that are 
medically unexplainable is one of the most common class of symptoms in patients 
visiting their primary care doctor and depression is highly associated with these 
patients15 • However, many diagnoses of depression are missed because physicians' main 
concern may be ruling out any life-threatening organic/somatic pathology in the patient. 
Screening, as recommended by the United States Preventive Services Task Force, has 
reduced the number of missed depression diagnoses, but detection is still sub-optimal. 14 
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Patients are more likely to receive the minimum adequate therapy in psychiatric 
settings than in primary care settings16. Of patients who are started on antidepressants in 
the primary care setting, 40% stop their therapy within a month likely attributed to low 
levels of follow-up in the primary care setting17 . However, when treatment is adequate in 
primary care settings it has been shown that the likelihood of recovery is identical to that 
of patients treated in psychiatric settings. The tendency to seek help first at primary care 
settings may reflect reluctance on the part of patients to see a psychiatrist or mental 
health professional and thereby be stigmatized. Many patients establish a certain rapport 
with their doctor and don't feel comfortable sharing intimate details of their life with a 
new doctor. At any rate, patient preference for depression management in primary care 
settings coupled with the limited psychotherapy skill set and limited time among primary 
care physicians makes some form of integration of psychiatric services into primary care 
settings an attractive solution for the management of depression. 
Given that general medicine/ primary care sector is the main access point for 
mentally ill patients (more people are seen in the general medical setting than in the 
specialty mental health sector), it seems like a good place for intervention. However, the 
NCS-Replication study demonstrates that patients seen in the general medical setting are 
more likely to be undertreated than adequately managed (33.2% vs. 66.8%), while in the 
specialty mental health sector more patients are adequately managed than undertreated 2. 
Many people first seek care with their primary care doctor because they trust that person 
and have a certain level of rapport. 
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There is also stigma that remains with regard to psychiatrists and psychiatric 
illness that may make seeking care with primary care docs more attractive for many 
patients. In a 2003 examining stigma associated with depression, it was shown that 67% 
of depressed primary care patients surveyed thought that depression related stigma would 
have a negative impact on employment, 59% reported a probable negative impact on 
health insurance, an 24% on friendships. In this study, stigma of depression was greater 
than that for hypertension or diabetes but less than that of HIV 12. 
Thus for many reasons, integration of psychiatric services into primary care 
settings is a promising concept. Collaboration between the specialty mental health sector 
and the primary care sector promises to capitalize on the preferred setting modality for 
many patients and incorporates the specific training for mental illness management that is 
concentrated in the specialty mental health sector. There are many different types of 
potential models for this integration. Collaboration model types include but aren't limited 
to: 
• Co-location- A mental health specialists is located on-site at a primary 
care doctor's office for a set number of hours each week and sees the 
generalists complicated psychiatric patients on a consult basis for a 
specified amount of time and this releases the patient back to the care of 
the generalist once stabilized. 
• Phone Consultation- Similar to co-location, partnerships between primary 
care doctors and mental health specialists are set up to allow telephone 
consultation for a certain number of hours each week. 
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• CME Training for Primary Care Docs- This collaboration model involves 
increasing the knowledge base and amount of training that primary care 
doctors for mental illness management through workshops and lectures 
conducted by mental health specialists. 
• Evidence-Based Disease-Specific Protocols- This model of collaboration 
involves development of evidence-based disease-specific protocols by 
mental health specialists to be utilized by primary care doctors. 
This paper will review current literature to assess whether integration of 
psychiatric services into primary care settings or other collaboration between primary 
care and mental health professionals leads to improved major depression treatment 
outcomes in non-pregnant/non-post-partum US adults and if so, which models 
demonstrate the most potential. 
Methods 
An electronic search of PubMed database was conducted. Original articles 
meeting eligibility criteria, articles fouod via bibliographic search by hand, and articles 
fouod at the advice of an expert in the field will also be included in this review. 
Inclusion Criteria: 
In order to be included in the systematic review, papers, studies, or commentaries must 
meet the following criteria: 
-Demonstrate some form or model of integration of psychiatric services into a 
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primary care setting or some other form of direct collaboration between mental 
health professionals and primary care professionals 
-Examine this model of integration in non-pregnant/non-postpartum US adult 
patients 
-Demonstrate some quantitative measure of patient based outcome measures in 
the management of Major Depression in comparison to the absence of 
collaboration or integration 
-Written in English 
-A Randomized Controlled Trial 
Exclusion Criteria 
Papers, studies, and commentaries will be excluded if they can be described as the 
following: 
-Intervention doesn't assess specific quantitative outcome measures 
-Collaboration is present but not between primary care and psychiatric 
Professionals 
-Written in a language other than English 
-Study examines post-partum depression, as opposed to other forms of depression 
-Study not performed in the United States 
-Articles written before 1975 
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Search Terms 
The first search was done using PubMed which contains articles for over 4800 
articles on a host of different medical topics from 1951 to the present. The following 
search terms were used in PubMed: 
-("Primary Health Care"[Mesh] OR "Family Practice"[Mesh] OR "physical 
health"[AII Fields]) AND ("Mental Health Services"[Mesh] OR "Community 
Mental Health Services"[Mesh] OR "Behavioral Mediciue"[Mesh] OR "behavioral 
health"[AII Fields] OR "Psychiatry"[Mesh]) AND ("Delivery of Health Care, 
Integrated"[Mesh] OR "iutegrated"[Ail Fields] OR "integration"[AII Fields]) AND 
("humans"[MeSH Terms] AND English[lang]) AND depression 
This search term retrieved 44 titles 
-"Depressive Disorder"[MeSH] OR "Depression" [MeSH] AND "Cooperative 
Behavior" [MeSH] AND "Psychiatry" [MeSH] AND "Primary Health Care" 
[MeSH] 
This search term retrieved 5 results 
-"Integration of Psychiatry into Primary Care for Depression" 
This search term retrieved 13 results 
-"Psychiatry and Primary Care Collaboration and Depression" 
This search term retrieved 49 results 
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Figure 2: Article Selection Summary 
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Article Selection 
After performing the searches as listed above and eliminating duplicate titles 98 article 
titles were reviewed (See Appendix A for Title List). Based on title review 64 articles 
were excluded based on the title for incongruence with topic of interest or for lack of 
outcome measures of interest for this paper. Abstracts for the remaining 34 articles were 
reviewed. After review of these abstracts, 22 additional articles were excluded based on 
the aforementioned exclusion criteria. Eleven full articles were pulled and carefully 
reviewed for inclusion in this systematic review according to the aforementioned 
inclusion/exclusion criteria. During review of these articles, 3 additional articles were 
added as possibilities based on bibliographic survey. Of these 14 full articles, 4 met 
criteria for inclusion (See Figure 3). 
The articles selected for review were also assessed for quality. Using criteria 
established by the Center for Reviews and Dissemination, articles were evaluated for 
criteria based on a 9 question inventory. This inventory is used a proxy to evaluate the 
internal validity of each individual article. For each article evaluated, a point was given 
for each component of the inventory, and the article was allocated a quality score of 
Good (7-9 points), Fair (5-6 points), or Poor (>4 points). All of the studies received 
"Good", quality ratings except for the PRISM-E study. While cited as an randomized 
controlled study, the PRISM-E trial had both randomized and non-randomized 
components, which diminished the internal validity. 
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Study Quality Quality # 
Study Type Intervention Score Rating Participants Year 
Collaborative Care team 
CC vs CL RCT vs Consult Liaison care as 7 Good 354 2003 
Care per usual 
Co-location vs Referral to 
PRISM-E RCT Free-Standing Mental 6 Fair 1531 2006 
Health Facility 
Mental Health T earn-
IMPACT RCT based case mgmt vs 8 Good 1801 2002 
U sua! PCP care 
Telephone Telephone Care & 
Psychotherapy/ RCT Psychotherapy+ Rx vs 8 Good 600 2004 
CareMgmt Phone Care+ Rx vs 
Rx Alone 
Results 
The Collaborative Care Depression management trial was conducted in 4 separate 
General Internal Medicine Clinics (GIMCs) that are part of the Seattle Division of 
Department of Veteran's Affairs. Potential subjects were patients who had not yet been 
recognized or had not yet begun treatment for depression and were recruited from 
January 1998 to March of 1999. Potential subjects were identified using for different 
methods. 
1. Waiting room patients were targeted with a 2-stage screening questionnaire 
2. Participants in another ongoing study were mailed a screening questionnaire 
19 
3. Patients screened during clinic check-in with screening questionnaire 
4. Referral by primary care providers 
Of the patients identified by the initial screening methods who were not already under 
care for depression, 354 patients agreed to participate in the study. Of these participants 
over half were identified based on provider referral (198). 
Of the 4 participating GIMC's, 2 clinics were randomized to the Collaborative 
Care Management and the other 2 clinics were randomized to the Consult-Liaison Care 
or Usual Care arm of the study. Participants were randomized to a particular clinic and 
thus a particular arm of the study. The Collaborative care team consisted of a clinical 
psychologist, psychiatrist, social workers, and a psychology technician that met weekly to 
discuss treatment plans and then to conduct progress evaluations at 6 and 12 weeks. This 
team then communicated this information to the primary care provider via electronic 
progress notes. In order to keep everyone informed of the treatment plan and progress a 
"co-signature" method was invoked to require that all providers be aware of all 
communications about the patient before proceeding. Patients were managed with any 
combination of antidepressants, cognitive behavior therapy, patient education videotape, 
and/or telephoned social worker support that was decided upon by the Collaborative Care 
Team. The Consult Liaison Team used a more traditional model wherein the primary care 
provider was responsible for the initiation of antidepressant management with consult to 
specialists as needed. Specialists were available to CL providers for the same number of 
hours as the Collaborative Care in an attempt to eliminate the possibility of CC group 
patients doing better just because they had more time with specialists. Depression 
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outcomes and overall health status were measured using the Hopkins Symptom Checklist 
(SCL-20), Veteran Short Form Health Status Questionnaire (SF-36) (which consists of 
both physical and mental components), and the Sheehan Disability Scale. These 
outcomes were evaluated at baseline and again at 3 and 9 months. SCL-20, SF-36, 
Sheehan scores taken at 3 and 9 months were analyzed using linear regression models. 
Analyses were performed by intention to treat method. 
There was a relatively high rate of retention for Collaborative Care and Consult 
Liaison groups at the 3 (93% vs 92%) and 9 (90% vs 94%) month time points. These two 
groups were not statistically different at baseline except that participants randomized to 
the Collaborative care groups were more likely to have had more previous episodes of 
depression than those in the Consult Liaison arm of the study. Collaborative Care 
treatment group experienced a statistically significant 0.34 point decrease in SCL-20 
score (ranges from 0-4 with higher number indicating increased disease severity) as 
compared with 0.14 for the Consult Liaison group. At 9 months, the Collaborative Care 
group still maintained a greater decrease in the SCL-20 score than the Consult Liaison 
group (0.41 vs. 0.25) but this was not found to be statistically significant. The number of 
patients experiencing a 50% decrease in SCL-20 score is used to evaluate the extent of 
clinical improvement of symptoms. The number needed to treat can be calculated using 
the failure to attain treatment response as an adverse event from which to calculate the 
absolute risk reduction. From this perspective the relative rates of the adverse event in the 
intervention group are 82.8% at 3 months and 81.9% at 9 months. For the control group 
those same rates are 88.2% and 84.9% at 3 and 9 months respectively. Based on these 
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values, the number needed to treat for this particular intervention is 18.52 at 3 months 
and 33.333 at 9 months. In terms of disability, as measured by Sheehan Disability Scores, 
the Collaborative care group experienced significant improvement in disability at 3 
months and continued improvement at 9 months that was not significant while 
participants in the Consult Liaison group experienced an increase in disability score. 
Lastly, participants were evaluated using the SF-36. In unadjusted analyses, 
Collaborative care patients demonstrated clinically significant improvements more than 
that of the Consult-Liaison groups on the mental components of the SF-36 both at 3 
months and 9 months, but these differences were attenuated after the making adjustments 
within each group for baseline MCS scores, demographic variables, history of prior 
depressive episodes, and potential provider clustering. It is believed that the # of previous 
depressive episodes is most likely responsible for the attenuation. Both groups 
experienced improvement in the physical component of the SF-36, with no statistical 
difference between groups. Lastly, patients in both treatment groups were equally highly 
satisfied with their primary care provider's management of their depression. 
Having entire clinics each devoted to one arm of the study or the other, makes it 
difficult to account for clinic by clinic differences that could potentially confound any 
differences found between the two groups. This compromises the internal validity of this 
study somewhat. Also, in terms of the initial comparability of the two groups, the 
Consult -Liaison group had significantly fewer patients with a previous episode of 
depression. These evaluation tools (SCL-20, SF-36, and Sheehan Disability Scale) used 
with blinded assessors really minimize any potential measurement bias. 
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The Primary Care Research in Substance Abuse and Mental Health for the Elderly 
(PRISM-E) Study compares the clinical depression outcomes in patients who receive 
integrated care (mental health services co-located within a primary care office with no 
separate signage) versus patients who received enhanced specialty referral for 
management (which included referral to a physically separate substance abuse or mental 
health clinic) 18. This was a multi-site trial conducted in 10 different urban, rural, and 
suburban primary care facilities (including 5 VA Medical Centers). A total of24,930 
patients were screened for psychiatric symptoms using the General Health Questionnaire, 
which was scored from 0 to 12, with higher scores being indicative of greater levels of 
depression or anxiety. A total of 1531 patients were included in the study with a mean 
age of73.9 years. At 8 of the 10 sites, patients were randomly assigned to the different 
arms of the study using a permuted block design to ensure equal assignment to each arm 
at each clinic, stratified by diagnostic category and age group. In the last two clinics, in 
lieu of randomization, patients were systematically allocated to a study arm on the basis 
of social security number. Thus the study does not have a completely pure randomization. 
The Integrated Care arm of the study occurred in practices where mental health and 
substance abuse services were co-located in a primary care office setting with no 
distinction or signage to indicate that services were rendered by a mental health 
professional. Other criteria included: 
-sites had to have some form of written communication about the assessment and 
plan between the mental health professional and the primary care provider 
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-appointments for mental health services had to be available within 2 weeks of the 
primary care visit 
For the enhanced specialty referral model: 
-Patients had to be referred to available appointment with mental health 
professional within 2-4 weeks of the primary care provider appointment 
-Mental health services are rendered in a physically separate location to which 
transportation was ensured 
-Mental health professionals ensured telephone follow-up after the patients first 
missed visit 
For each group depressive symptoms were measured via the Center for Epidemiological 
Studies Depression Scale (CES-D) and mental functioning quantified by the Mental 
Component Score (MCS) of the Short Form 36 (SF-36) at 6 and 12 months after 
initiation of therapy. Also, patients were evaluated for complete remission of symptoms 
at the 6 month follow-up appointment. Model fidelity was ensured as the various sites in 
the PRlSM-E trial were evaluated on a regular basis. 
The baseline characteristics of the 1531 participants were not different between 
the two groups. The majority of the participants were male due in part to the high 
percentage ofparticpants from Veteran's Affairs clinics. Participants had an average of 
5.1 co-morbid chronic diseases. This study made distinction between types of depression 
diagnoses. Sixty-three percent of participants had major depression, 21% had minor 
depression, 7% were diagnosed with dysthymia, and 9% were diagnosed with depression 
not otherwise specified. Assessments indicated overall decline in depression severity, 
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indicated by decreased CES-D scores, with a trend toward greater reduction among 
patients in the enhanced referral arm of the study. Within the strata of patients with major 
depression, the enhanced specialty referral group demonstrated statistically significant 
greater reduction in depression severity when compared with integrated care group (-I 0.2 
+/- 12.! vs. -7.5 +!- !3.!, p=0.003). Both groups demonstrated improvement in MCS 
scores of 5 points but with no statistical difference between groups. Finally, there was no 
significant difference in the rates of remission between the two arms of this study at 6 
months. Some secondary analyses of the date, also indicated that talk-therapy plus 
pharmacotherapy worked better in enhanced referral groups than in integrated care model 
for major depression. There was also a correlation between the number of chronic 
illnesses at baseline and poorer clinical outcomes in the sub-group of patients with major 
depression. 
The measurement tools in this study are equal, valid, and reliable thus minimizing 
measurement bias. Also in the PRISM-E Study, patients who qualified for the study 
based on the General Health Questionnaire (GHQ) but refused to participate were more 
likely to be male, have lower GHQ scores (indicating lower levels of depression) and 
report more drinks consumed per week. There may be some selection bias for patients 
screened in to participate versus those patients in the general patient population who were 
less depressed than those who refused to participate. While the internal validity is quite 
good for this specific sub-population, the external validity is quite limited given the 
characteristics of the study population. 
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The IMPACT trial (Improving Mood- Promoting Access to Collaborative 
Treatment Program) is a multi-site randomized controlled trial examining the impact of 
integrated behavioral health services for better outcomes in primary care management of 
depression19• A total of 1801 patients diagnosed with depression were enrolled from 18 
primary clinics across the country. Patients were recruited between July 1999 to August 
2001 using referrals of depressed patients from primary care providers and using a 2-item 
screener for all patients visiting the primary care clinic. Patients were randomized to 
receive usual care or the IMP ACT integrated care intervention stratified by recruitment 
method using a random number sequence generator. Patients enrolled in the IMP ACT 
arm of the trial were assigned to a Depression Care Specialist (DCS) and on the initial 
visit watched a 20-minute video on late-life depression and had their first visit with the 
DCS, during which the DCS took a psychosocial history, reviewed education materials, 
and discussed patient preferences for treatment (psychotherapy vs. pharmacological 
management). A treatment plan was then developed under collaboration between a 
supervising psychiatrist, primary care physician, and the DCS. Patients in this arm of the 
study had access to an IMP ACT care manager for a time period of 1 year from the 
baseline assessment. All prescriptions for anti-depressants were written by the primary 
care physicians. Outcomes assessed included self-reported use of antidepressants or 
psychotherapy, satisfaction with depression care, average SCL-20 scores, and then 
assessment of treatment response vs. remission based on the amount of decrease of SCL-
20 scores (>/= 50% decrease vs. score<0.5 respectively). All patients were followed for a 
year and evaluated at baseline, 3, 6, and 12 month intervals. Baseline interviews included 
26 
a Sheehan disability scoring in addition to the other modalities evaluated at the follow-up 
time points. Interviews were conducted by trained interviewees that were blinded to the 
subject's intervention condition. 
The usual care and IMP ACT intervention groups were not statistically different in 
analysis oftheir baseline characteristics. Patients reported a mean of3.2 common co-
morbid chronic conditions. Forty-six percent of patients enrolled reported some form of 
antidepressant management in the past 3 months (psychotherapy or pharmacological). 
Patients in the intervention group were more likely to continue using antidepressants or 
psychotherapy longer than patients in the usual care group (average of6.6 months of 
antidepressant use vs. 4.6 months respectively, p<.001). Intervention patients 
demonstrated statistically significant lower depression severity scores at all time points, 
with the difference between groups increasing from 3 months to 12 months. Also, more 
patients from the intervention group met criteria for treatment response or for complete 
remission of symptoms based on criteria set forth in methods. In terms of treatment 
response, the number needed to treat is calculated using the failure to attain treatment 
response as an adverse event from which to calculate the absolute risk reduction. From 
this perspective the number needed to treat in the intervention group is 5.87 at 3 months, 
5.43 at 6 months, and 3.93 at 12 months. Lastly, intervention patients reported less 
health-related functional impairment and greater overall quality oflife in the past month 
compared to the usual care patients. The cost of the IMPACT intervention was found to 
be $533 per intervention patient for the 12 month period. 
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Selection bias, measurement bias are minimized quite well in the study indicating good 
internal validity. However, given that only persons over the age of 60 were enrolled, the 
external validity is somewhat validity. 
The last study examined the role of telephone psychotherapy and telephone care 
management in primary care management of depression20. Patients were recruited 
between November 2000 and May 2002 from 7 primary clinics that are part of the Group 
Health Cooperative, which is a pre-paid health plan serving many Washington state 
residents. The target population for participation in the study includes patients who are 
about to be started on antidepressant therapy by their primary care provider. The study 
excluded patients who were already receiving psychotherapy or that were in remission at 
the start of the study. Patients were identified using computerized pharmacy records and 
visit registration records. A total of 1883 patients were identified and after eliminating 
ineligibles and patients not interested in participating a total of 600 patients were 
randomly assigned to one of three treatment groups: I. Usual primary care management, 
2. Telephone care management, or 3. Telephone care management plus telephone 
psychotherapy. Patients enrolled in the usual management portion of the study were not 
contacted after the baseline assessment again until the first outcome evaluation. Patients 
enrolled in the telephone care management portion of the study were contacted frequently 
via phone by care managers who assessed depressive symptoms, medication use, and 
adverse effects. This information was then reported to the primary care physician with 
recommendations for adjustment noted. Patients assigned to the telephone psychotherapy 
and telephone care management arm of the study received all components of the 
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telephone care management portion of the study in addition to 8 structured cognitive 
behavioral psychotherapy sessions. Telephone counselors were psychotherapists with a 
master's degree and at least 1 year of experience in outpatient psychotherapy. These 
counselors received didactic instruction and at least 60 minutes of supervision from a 
psychologist or psychiatrist each week. Outcomes of interest in this study include 
1. Self-rated global improvement 
2. SCL Depression Scale 
3. Patient Health Questionnaire 
4. Survey of patient satisfaction with Depression management 
All participants were evaluated at 6 weeks, 3 months, and 6 months by phone by 
experienced interviewers that were blinded to each participant's intervention condition. 
All data analyses were conducted based on intention to treat. 
Aside from the different percentage of white participants, the baseline 
characteristics between groups were not different. The largest improvement in depression 
severity as measured by SCL-20 scores was demonstrated in the telephone/psychotherapy 
group, intermediate in the telephone care group, and least in the usual care group. 
Significantly more patients in the telephone/psychotherapy group experienced a 50% 
reduction in SCL score than telephone care manager, and usual care groups respectively 
(100 (58%) vs. 94(51 %) vs. 76(43%), p value=.005 comparing telephone/psychotherapy 
to usual care). The number needed to treat can be calculated using the failure to attain 
treatment response as an adverse event from which to calculate the absolute risk 
reduction. From this perspective the relative rates of the adverse event in each group are 
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42%, 49%, and 57% respectively for the telephone psychotherapy/care manager, the 
telephone care manager, and the usual care groups. In this case, in the telephone care 
manager group, the number needed to treat is equal to 11(0.57-0.49)= 12.5. The number 
needed to treat for the telephone psychotherapy/care manager group is equal to 
11(0.57-0.42)=6.6667. Telephone/psychotherapy and telephone care manager groups 
were significantly more likely than usual care patients to rate themselves as "much 
improved" or "very much improved" at all time points. 
In this study, selection bias, measurement bias are very well minimized indicating 
good internal validity. 
Discussion 
This review aimed to evaluate interventions that combined psychiatric services in 
some form into the primary care setting and compared these outcomes to that of the 
absence of the intervention. Three ofthe studies compared integrated interventions to 
usual care in the primary care setting while the fourth study compared and integrated 
intervention to care in the psychiatric setting. Of the three studies that examined 
outcomes from an integrated intervention vs. that of usual care in the primary care 
setting, the integrated model always demonstrated better clinical depression outcomes, 
overall health status, and satisfaction with treatment. It appears that some form of 
facilitator charged with regularly following-up on the patient's progress (by phone) 
consistently provided better outcomes than in the absence of this intervention. In the 
studies examined here this takes the form of either depression care specialists (DCS) or 
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Collaborative Care team or Telephone care managers. This worked particularly well 
when this facilitator was in constant communication and under the supervision of both 
the primary care provider and a mental health specialist. This implies the importance of 
chronic follow-up and collaborative re-evaluation of the treatment plan based on the 
patient's progress at a rate more frequent than may be feasible for a PCP to provide 
without the appropriate infrastructure. Of the studies, that showed improved outcomes 
with integrated models, SCL-20 score (Hopkins Symptom Check List) was an outcome 
measure of interest in each. Treatment response, defined as a >/=50% decrease in SCL-
20 from baseline score was evaluated as an accepted indicator of clinical improvement. In 
the Consult-Liaison/Collaborative Care study, 17.2% of patients in the Collaborative 
Care group had SCL scores that were <50% of their baseline value at month 3 and 
similarly 18.1% at 9 months. In the IMPACT trial, 49.34% experienced a 50% decrease 
in SCL-20 score by month 6, compared with 30.92% of the usual care group. Finally in 
the Telephone/Psychotherapy study, 43% of usual care patients experienced a 50% 
reduction treatment response by 6 months, compared with 51% of the Telephone Care 
Management Group and 58% of the Telephone Care Management group plus 
Psychotherapy. Based on these measures, it appears that Telephone Care Management 
plus Psychotherapy demonstrated the greatest trend in terms of the extent of treatment 
response. However, when the number needed to treat is compared across the 
interventions for the outcome that best leads to treatment response, the DCS model from 
the IMPACT appears to require the least number of patients to be treated in order to 
avoid I treatment failure. 
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In the PRISM-E study, co-location in a primary care setting was compared with 
enhanced psychiatric care, and the enhanced psychiatric care modelled to better clinical 
depression outcomes than the integrated model. It is difficult to draw conclusions from 
this study. While the integrated intervention doesn't lead to better outcomes than the 
usual psychiatric care model, it can't be determined from the information provided, 
whether the integrated care intervention would lead to better outcomes than usual care in 
the primary care setting. 
Based on the pool of evidence surveyed for this review, it seems that psychiatric 
care integrated into primary care settings, except for co-location, leads to better 
depression outcomes. And amongst these kinds of interventions, it is apparent that 
strategic chronic follow-up and collaborative re-evaluation of the treatment plan are key 
in maximizing outcomes. It would thereby follow that primary care physicians can 
maximize treatment outcomes for their patients by developing an algorithm for 
depression management that includes a thorough introduction to the diagnosis, a 
designated number of office-initiated follow-up calls/visits, and with treatment plan 
changes guided by patient feedback as well as generalist/psychiatrist collaboration. 
Challenges to such a system include competing priorities in primary care physician 
workload, poor reimbursement for added office time/resources, and difficulty arranging 
presumably frequent consultation with mental health professionals. It will also be 
important that offices be able to triage new diagnoses of depression to see which cases, if 
not every case, would benefit from the enhanced depression management algorithm. 
More research should be done to develop screening tools that quickly and appropriately 
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identifY patients that would most benefit from the enhanced depression management 
model. 
In terms of cost, it has already been shown that while collaborative management 
interventions increase the cost of management of any given case of depression, they also 
increase the number of QUAL's (Quality Adjusted Life Years), decrease depression 
burder, and increase the average number of days working (fewer missed days) when 
compared with usual care21 . The cost of the IMP ACT trial was specifically evaluated to 
find that integrated measures in the primary care management of depression cost more 
but lead to lower overall healthcare costs over 4 years. The more the cost of collaborative 
care interventions can be further characterized in future research, this will continue to 
help to build the case for the utility of collaborative care. 
Limitations 
The generalizability of this review of the literature is limited by the search terms 
. and inclusion/exclusion criteria selected. Based on these criteria, few articles were fully 
reviewed and this potentially limits the population to which the conclusions drawn here 
can be extrapolated. Over half of all the patients in the studies included in this review 
were in late-life so it would be difficult to extrapolate this information to other age 
groups as there may be mitigating circumstances that account for differences in the 
pathophysiology of depression in different age groups. 
Lastly, it was difficult to evaluate or draw any conclusions about the role of 
stigma in depression management in primary care. In the PRISM trial, patients who were 
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treated in the psychiatric setting fared better than those managed within the primary care 
setting with no signage (thus to minimize stigmatization). However, few conclusions can 
be drawn about stigma in this case because the superior depression outcomes may be 
attributed to factors that have little to do with stigmatization or the use of the psychiatric 
setting may have added benefits that outweighed the alleviation of stigma. 
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Figure 3 
PRISMME'. Comparison of 
Integrated Care and Enhanced 
Specialty Referral Models in 
Depression Outcomes 
Collaborative Care Management of 
LatewLife Depression in the 
Primary Care Setting 
(IMPACT) 
Telephone Psychotherapy and 
Telephone Care Management for 
Primary Care Patients Starting 
Antidepressants 
Dean D. Krahn, MD 
Jurgen Unutzer, MD, 
MPH 
2006 
2002 
Gregory E. Simon, MD II 2004 
MPH 
Randomized 
Controlled Study 
RCT 
RCT 
consists of a clinical 
psychologist, psychiatrist, 
social workers, and a 
psychology technician) [CC] 
vs. Consult-Liaison 
management per usual. 
Patients randomly assigned 
to groups receiving 
integrated care in the form 
of co-location or referral to 
a separate mental health 
facillity. 
Care Management for one 
year supervised by a 
psychiatrist and offered 
education, care mgmt, rx 
mgmt, and psychotherapy 
compared to the non-
intervention group that 
received usual care in the 
primary care setting 
Two Intervention 
Groups:Telephone Care+ 
Telephone Psychotherapy in 
addition to Antidepressant, 
Telephone Care+ 
Antidepressant, and 
Antidepressant in the setting 
of usual primary care mgmt. 
Symptoms (Hopkins Sx 
Checklist), 2. Health 
Status (SF-36), 3. 
Disability (Sheehan 
Scale), 4. Patient 
Satisfaction (Katon ), 
5. Antidepressant Tx 
Adequacy; at baseline, 
3, and 9 months ' 
l. Depressive 
Symptoms (Center for 
Epidemiological Study 
Depression Scale (CBS-
D)), 2. Mental 
functioning as 
measured by the mental 
component score of the 
Short Form 36 (SF-36), 
3. Remission of sx at 
6mos flu using MINI 
I. Self-Reported use of 
anti-depressants and/or 
psychotherapy, 2. 
Satisfaction with 
depression care, 3. 
Treatment Response as 
measured by 
improvement in SCL-
20 scores, 4. Health 
related functional 
impairment/quality of 
life 
I. Severity of 
Depression Sx 
(Hopkins Sx Checklist 
and PHQ-9}, 2.Patient 
rated improvement, 3. 
Satisfaction with 
Treatment 
CC pts had 
significantly faster 
improvement of 
depression sx@ 3 mas 
& no diff@ 9mos. CC 
had significantly 
decreased disability at 
3 mas as compared 
with the CL group, no 
difference at 9 mos. 
I. Reduction in CES-D 
severity in both groups 
with greater reduction 
in the Enhanced 
Referral grp (off-site), 
2. Similar 
improvement of mental 
functioning by the SF-
36 between both 
groups, 
Intervention group had 
significantly lower 
depression as 
measured by the SCL-
20 at all timepoints, 2. 
Intervention patients 
also reported less 
health related 
functional impairment 
as compared to the 
usual care group. 
Compared with usual 
care, telephone care & 
psychotherapy pts 
experienced greater 
improvement in HSC-
DS, self rated 
improvement, and 
satisfaction with 
treatment 
(randomized study, 
patient group charts show no diffin grps at 
baseline) BUT limited external validity and 
possibility of understated benefit based on 
structure of the CC workgroup. 
I. Good internal validity but elderly popula 
limits external validity, 2. Does not include 
any comparison to primary care manageme 
alone. 
Population >60 decreases external validity. 
35 
Works Cited 
1. Prince M, Patel V, Saxena S, eta!. No health without mental health. The Lancet. 
2007;370(9590):859-877. 
2. Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC. Twelve-month 
use of mental health services in the United States: results from the National 
Comorbidity Survey Replication. Arch GenPsychiatry. Jun 2005;62(6):629-640. 
3. Services USDoHaH. Mental Health: A Report of the Surgeon General--
Executive Summary. Rockville, MD: US Department of Health and Human 
Services, Substance Abuse and Mental Health Services Administration, National 
Institutes of Health, National Institute of Mental Health; 1999. 
4. Kessler RC, McGonagle KA, Zhao S, eta!. Lifetime and 12-month prevalence of 
DSM-III-R psychiatric disorders in the United States. Results from the National 
Comorbidity Survey. Archives of General Psychiatry. 1994;51(1):8-19. 
5. Olfson M, Marcus SC, Druss B, Elinson L, Tanielian T, Pincus HA. National 
Trends in the Outpatient Treatment of Depression. JAMA. Vol287: Am Med 
Assoc; 2002:203-209. 
6. Pampallona S, Bollini P, Tibaldi G, Kupelnick B, Munizza C. Combined 
Pharmacotherapy and Psychological Treatment for Depression: A Systematic 
Review. Archives of General Psychiatry. 2004;61(7):714. 
7. American Psychiatric Association., American Psychiatric Association. Task Force 
on DSM-IV. Diagnostic and statistical manual of mental disorders: DSM-IV. 4th 
ed. Washington, DC: American Psychiatric Association; 1994. 
8. Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER. The economic burden of 
depression in 1990. J Clin Psychiatry. 1993;54(11):405-418. 
9. Stewart WF, Ricci JA, Chee E, Hahn SR, Morganstein D. Cost of Lost Productive 
Work Time Among US Workers With Depression. JAMA. Vol289: Am Med 
Assoc; 2003:3135-3144. 
10. Kessler RC, Chiu WT, Demler 0, Walters EE. Prevalence, Severity, and 
Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity 
Survey Replication. Archives of General Psychiatry. 2005;62(6):617. 
11. Davidson JR, Meltzer-Brody SE. The underrecognition and undertreatment of 
depression: what is the breadth and depth of the problem? J Clin Psychiatry. 
1999;60 Suppl 7:4-9; discussion 10-11. 
12. Roeloffs C, Sherbourne C, Uniitzer J, Fink A, Tang L, Wells KB. Stigma and 
depression among primary care patients. General Hospital Psychiatry. 
2003;25(5):311-315. 
36 
13. Wang PS, Demler 0, Olfson M, Pincus HA, Wells KB, Kessler RC. Changing 
Profiles of Service Sectors Used for Mental Health Care in the United States. 
American Journal of Psychiatry. 2006;163(7):1187. 
14. Pignone MP, Gaynes BN, Rushton JL, eta!. Screening for Depression in Adults: 
A Summary of the Evidence for the US Preventive Services Task Force. Annals of 
Internal Medicine. 2002;136(10):765. 
15. Henningsen P, Zimmermann T, Sattel H. Medically Unexplained Physical 
Symptoms, Anxiety, and Depression: A Meta-Analytic Review. Psychosomatic 
Medicine. Vo165: Am Psychosomatic Soc; 2003:528-533. 
16. Kessler RC, Berglund P, Demler 0, Jin R, Merikangas KR, Walters EE. Lifetime 
Prevalence and Age-of-Onset Distributions ofDSM-IV Disorders in the National 
Comorbidity Survey Replication. Archives of General Psychiatry. 
2005;62(6):593. 
17. Simon GE, Von KorffM, Rutter CM, Peterson DA. Treatment process and 
outcomes for managed care patients receiving new antidepressant prescriptions 
from psychiatrists and primary care physicians. Arch Gen Psychiatry. Apr 
2001 ;58( 4):395-401. 
18. Krahn DD, Bartels SJ, Coakley E, eta!. PRISM-E: comparison of integrated care 
and enhanced specialty referral models in depression outcomes. Psychiatr Serv. 
Jul2006;57(7):946-953. 
19. Unutzer J, Katon W, Callahan CM, eta!. Collaborative care management of late-
life depression in the primary care setting: a randomized controlled trial. Jama. 
Dec II 2002;288(22):2836-2845. 
20. Simon GE, Ludman EJ, Tutty S, Operskalski B, Von KorffM. Telephone 
psychotherapy and telephone care management for primary care patients starting 
antidepressant treatment: a randomized controlled trial. Jama. Aug 25 
2004;292(8):935-942. 
21. Schoenbaum M, Unutzer J, Sherbourne C, eta!. Cost-effectiveness of practice-
initiated quality improvement for depression: results of a randomized controlled 
trial. Jama. Sep 19 2001 ;286(11):1325-1330. 
37 
